Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
27 studies found for:    Open Studies | "Drug Hypersensitivity"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Drug Hypersensitivity"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Management of Drug Hypersensitivity in Children
Condition: Drug Hypersensitivity
Intervention:
2 Recruiting Medical Device for Drug Allergy Diagnosis
Condition: Drug Hypersensitivity
Intervention: Procedure: Immediate hypersensitivity to BLC
3 Recruiting Optimal Doses for Drug Provocation Tests to Beta-lactams
Condition: Drug Hypersensitivity
Intervention: Procedure: simplified drug provocation test
4 Unknown † Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Condition: Drug Hypersensitivity
Intervention: Drug: anti-TNF a
5 Recruiting Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization
Condition: Drug Allergy
Intervention: Drug: Omalizumab
6 Recruiting Quality of Life of Patients With a History of Drug Allergy in Thailand
Condition: Quality of Life
Intervention: Other: Questionnaires
7 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
Intervention:
8 Recruiting Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Conditions: Allergic Cutaneous Vasculitis;   Urticaria;   Psoriasis;   Acne;   Bullous Skin Diseases;   Sterile Pustulosis;   Leprosy;   Pneumocystis Pneumonia
Intervention: Drug: Dapsone
9 Recruiting Comparison Between Corticosteroid and Topical Steroids in the DRESS
Condition: Drug Rash With Eosinophilia and Systemic Symptoms
Interventions: Drug: Prednisone;   Drug: Clobetasol
10 Not yet recruiting Role of Inflammatory Mediators in AERD
Condition: Asthma, Aspirin-Induced
Intervention: Drug: aspirin
11 Not yet recruiting Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Isotretinoin;   Other: Placebo
12 Not yet recruiting Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
Condition: Hand Foot Syndrome
Interventions: Drug: Traditional Chinese Medicine Formula LC09;   Other: Placebo
13 Not yet recruiting G-CSF in the Treatment of Toxic Epidermal Necrolysis
Condition: Stevens - Johnson Syndrome
Interventions: Drug: recombinant granulocyte - colony stimulating factor;   Drug: NaCl 0.9%
14 Recruiting The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia
Condition: Palmar-Plantar Erythrodysesthesia
Interventions: Device: Vitamin B6 cream;   Device: Placebo Vitamin B6 cream
15 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
16 Available Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation
Conditions: Limbal Stem Cell Deficiency;   Stevens-johnson Syndrome;   Ocular Cicatricial Pemphigoid;   Chemical Burn
Intervention: Biological: cultivated oral mucosal epithelial sheet transplantation
17 Recruiting High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Conditions: ASA Triad;   Asthma, Nasal Polyps, And Aspirin Intolerance
Intervention: Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
18 Recruiting MARY DUOL REPAIR BALM IN THE PREVENTION OR REDUCING ANTINEOPLASIC AGENTS' SKIN TOXICITY
Condition: Dermatitis, Adverse Drug Reaction
Interventions: Procedure: BALM ARM;   Procedure: PLACEBO ARM
19 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
20 Recruiting Testing the Effectiveness of Henna on Managing PPE
Condition: Palmar-plantar Erythrodysesthesia (PPE)
Interventions: Drug: Henna;   Drug: Placebo
To Top

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
† Indicates status has not been verified in more than two years